Categories
Tata Memorial Study: Nimotuzumab Boosts Survival in Head and Neck Cancer
New Delhi, July 30, 2024: A study conducted by Tata Memorial Hospital in Mumbai has shown that adding Nimotuzumab to the standard treatment regimen significantly [more…]